Catalyst
Slingshot members are tracking this event:
Genfit NASH program targeting Nonalcoholic Steatohepatitis with biomarkers plans to begin development in the second half of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 23, 2018
Occurred Source:
http://www.genfit.com/wp-content/uploads/2018/01/2018.01.23-PR-GENFIT-PSP-FDA.pdf
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Nonalcoholic Steatohepatitis, Biomarkers, Nash